Cequa Stability Issues

Discussion in 'Allergan' started by anonymous, Mar 1, 2021 at 9:10 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Restasis Reps should have a field day. Sun Reps have no samples of Cequa for the next couple of months. Stability issues with Cequa. Have you noticed hardly any samples of Cequa in MD shelves. Been on-going since January
     

  2. anonymous

    anonymous Guest

    No because there’s still 300 samples of unused, expired product from last year on the shelf.
     
  3. anonymous

    anonymous Guest

    Sun Reps are spinning it. Not being upfront about stability issues. Saying production backlog due to pandemic. No samples to provide to avoid having out of stock situation at trade which is total BS. There are batches that failed Quality Control that’s why samples and corresponding lot numbers were pulled off.
     
  4. anonymous

    anonymous Guest

    If your territory is even remotely being impacted by Cequa or the samples then you truly don’t know how to sell Restasis. Chump change.
     
  5. anonymous

    anonymous Guest

    Exactly
     
  6. anonymous

    anonymous Guest

    Clinics are not concerned with the stability issues. They think if it makes it to the patient all is good.
     
  7. anonymous

    anonymous Guest

    I’d be careful with this news. My manager wanted us to share so I told some of my Cequa writers and it didn’t go well. It was awkward and it probably made me look bad. I’m going to focus on discussing my products moving forward.
     
  8. anonymous

    anonymous Guest

    Thanks for the advice Sun Troll. I’ll do what I like. You have issues and providers should know.
     
  9. anonymous

    anonymous Guest

    We all k ow that you guys are afraid of Cequa. Quit spreading unfounded rumors about your new and obviously more effective daddy. Move on over ladies.
     
  10. anonymous

    anonymous Guest


    Lmao

    which ex-Allergan Sun employee posted that BS! Ha ha
     
  11. anonymous

    anonymous Guest

    That 2% market share is quite intimidating
     
  12. anonymous

    anonymous Guest

    Mass exodus from SUN. Sinking ship.
     
  13. anonymous

    anonymous Guest

    1/2 of their Rxs are coming from their mail order pharmacy which isn’t counted in our data. It’s a lot more than we see.
     
  14. anonymous

    anonymous Guest

    no. All pharmacies report. It’s still a tiny Rx volume. Not a player.
     
  15. anonymous

    anonymous Guest

    Not true. I know for a fact that the data from the pharmacy used for their mail order is not reported. ​